Automatic Prosthetic Foot Stiffness Modulation to Improve Balance
OSA
Automatic Activity-Dependent and Phase-Varying Prosthetic Foot Stiffness Modulation to Improve Balance Control in Individuals With Lower-Limb Amputations
2 other identifiers
interventional
20
1 country
1
Brief Summary
The goal of this clinical trial is to identify prosthesis stiffness that optimizes balance control in individuals with below knee amputations. The main question this clinical trial will answer is: • Is there an optimal stiffness that improves balance control for specific ambulatory activities and users? Participants will wear a novel prosthesis assembled with three prosthetic feet with a range of stiffness levels: each individual's clinically-prescribed foot stiffness and ± two stiffness categories. While wearing the study prostheses, participants will perform nine ambulatory activities of daily living (walking at different speeds, turning, ramp ascent/descent, while carrying a load, and while walking on uneven terrain).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 24, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedStudy Start
First participant enrolled
December 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedDecember 17, 2025
December 1, 2025
1.2 years
November 24, 2024
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peak-to-peak range of the frontal plane whole-body angular momentum
Frontal plane whole-body angular momentum is a measure of the extent to which a person will rotate in the frontal plane in the absence of an external force or torque. The peak-to-peak range quantifies how much this metric varies and is used to describe a person's balance.
During study visit (approximately 3 hours)
Study Arms (9)
Walking on 0% slope at self-selected speed
EXPERIMENTALAll participants will walk on a treadmill, in a straight line, on a 0% slope, at their self-selected walking speed determined while walking overground.
Walking on 0% slope at 15% slower than self-selected speed
EXPERIMENTALAll participants will walk on a treadmill, in a straight line, on a 0% slope, at a speed that is 15% slower than their self-selected walking speed determined while walking overground.
Walking on 0% slope at 15% faster than self-selected speed
EXPERIMENTALAll participants will walk on a treadmill, in a straight line, on a 0% slope, at a speed that is 15% faster than their self-selected walking speed determined while walking overground.
Walking up an 8% slope at self-selected speed
EXPERIMENTALAll participants will walk on a treadmill, in a straight line, up an 8% slope, at their self-selected walking speed determined while walking overground up an 8% slope.
Walking down an 8% slope at self-selected speed
EXPERIMENTALAll participants will walk on a treadmill, in a straight line, down an 8% slope, at their self-selected walking speed determined while walking overground up an 8% slope.
Walking on 0% slope at self-selected speed while hand carrying a 5 kg load on their prosthetic side
EXPERIMENTALAll participants will walk on a treadmill, in a straight line, on a 0% slope, at their self-selected walking speed determined while walking overground, while carrying a 5 kg load in one hand on their prosthetic side.
Walking on uneven terrain at self-selected speed
EXPERIMENTALAll participants will walk on an uneven terrain treadmill, in a straight line, on a 0% slope, at their self-selected walking speed determined while walking on the uneven terrain treadmill.
Walking around a 2-meter diameter circle with the prosthesis on the inside of the circle
EXPERIMENTALAll participants will walk overground while following the outline of a 2-meter diameter circle, at their self-selected walking speed determined while walking around the circle, with their prosthetic limb on the inside of the circle.
Walking around a 2-meter diameter circle with the prosthesis on the outside of the circle
EXPERIMENTALAll participants will walk overground while following the outline of a 2-meter diameter circle, at their self-selected walking speed determined while walking around the circle, with their prosthetic limb on the outside of the circle.
Interventions
A novel prosthesis that includes a low-profile prosthetic foot whose stiffness category is two categories less stiff than the as-prescribed stiffness.
A novel prosthesis that includes a low-profile prosthetic foot whose stiffness category is determined by the person's body weight and activity level (standard clinical practice).
A novel prosthesis that includes a low-profile prosthetic foot whose stiffness category is two categories stiffer than the as-prescribed stiffness.
Eligibility Criteria
You may qualify if:
- Unilateral transtibial (below-knee) amputation
- Been fit with a prosthesis and used it for at least 6 months
- Wear the prosthesis for 4 or more hours on average per day
- Be at least one-year post-amputation
- Able to walk on a treadmill
You may not qualify if:
- Presence of disorder, pain, or injury other than amputation that interferes with gait
- Current skin irritation or injury on residual limb
- Use of an assistive device for walking (cane, walker, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Puget Sound Healthcare System
Seattle, Washington, 98108, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Glenn Klute, PhD
US Department of Veterans Affairs
- PRINCIPAL INVESTIGATOR
Richard Neptune, PhD
The University of Texas at Austin
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 24, 2024
First Posted
December 2, 2024
Study Start
December 19, 2024
Primary Completion
March 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
December 17, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- Publication-associated datasets will be submitted to DASH at least 4 months prior to publication so that data can be shared on or before the initial publication date. The full study dataset will be submitted to DASH at least 6 months prior to the end of the award period. DASH does not currently have any data deprecation or sunsetting protocols, allowing shared data to be preserved for the foreseeable future.
- Access Criteria
- DASH is an NIH controlled-access data repository. The NICHD DASH Data Access Committee reviews all requests to access DASH data from identity-verified requesters to determine whether the proposed use is scientifically and ethically appropriate and does not conflict with constraints or research data use limitations identified by the institutions that submitted the research data. The Recipient's institution and the Recipient must sign and agree to the terms and conditions in the NICHD DASH Data Use Agreement for accessing research data.
De-identified data sets of all IPD collected throughout the trial will be made available, in machine-readable format, on the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH). The de-identification procedures will follow 164.514(a) of the HIPAA Privacy Rule.